Return On Equity	(Apr 30 2025) 2025	(Apr 30 2024) 2024	(Apr 30 2023) 2023	(Apr 30 2022) 2022	(Apr 30 2020) 2021
Y / Y Equity Change	-34.06 %	-39.9 %	-26.58 %	26.98 %	-
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

IPA all Ratios >> Back to IPA Management Effectiveness >> See Quarterly IPA Return On Equity

You need to upgrade your Flash Player

Financial Statements
Immunoprecise Antibodies Ltd 's Equity	$ 17 Millions	Annual IPA's Balance sheet
Immunoprecise Antibodies Ltd 's Annual Income	$ -22 Millions	Annual IPA's Income Statement
Where are IPA's Income coming from?		Visit IPA's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.